HN2011003102A - SUBSTITUTED PIPERIDINS - Google Patents

SUBSTITUTED PIPERIDINS

Info

Publication number
HN2011003102A
HN2011003102A HN2011003102A HN2011003102A HN2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A
Authority
HN
Honduras
Prior art keywords
piperidins
substituted
diseases
treatment
same
Prior art date
Application number
HN2011003102A
Other languages
Spanish (es)
Inventor
Heimbach Dirk
Rohrig Susanne
Cancho Grande Yolanda
Bender Eckhard
Zimmermann Katja
Buchmuller Anja
Gerdes Christoph
Gnoth Mark Jean
Gericke Kersten Matthias
Jeske Mario
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HN2011003102A publication Critical patent/HN2011003102A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

LA INVENCION SE REFIERE A NUEVAS PIPERIDINAS SUSTITUIDAS, A PROCEDIMIENTOS PARA SU PREPARACION, AL USO DE LAS MISMAS PARA EL TRATAMIENTO Y/O PROFILAXIS DE ENFERMEDADES Y AL USO DE LAS MISMAS PARA LA PRODUCCION DE MEDICAMENTOS PARA EL TRATAMIENTO Y/O PROFILAXIS DE ENFERMEDADES ESPECIALMENTE DE ENFERMEDADES CARDIOVASCULARES Y ENFERMEDADES TUMORALES.THE INVENTION REFERS TO NEW SUBSTITUTED PIPERIDINES, PROCEDURES FOR THEIR PREPARATION, THE USE OF THE SAME FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES AND THE USE OF THE SAME FOR THE PRODUCTION OF MEDICINES FOR THE TREATMENT AND / OR PROPHEERMAL SPECIES IN SPECIALTY OF CARDIOVASCULAR DISEASES AND TUMOR DISEASES.

HN2011003102A 2009-05-27 2011-11-24 SUBSTITUTED PIPERIDINS HN2011003102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009022894A DE102009022894A1 (en) 2009-05-27 2009-05-27 Substituted piperidines

Publications (1)

Publication Number Publication Date
HN2011003102A true HN2011003102A (en) 2015-02-23

Family

ID=42537882

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2011003102A HN2011003102A (en) 2009-05-27 2011-11-24 SUBSTITUTED PIPERIDINS

Country Status (29)

Country Link
US (3) US8440657B2 (en)
EP (1) EP2435431A1 (en)
JP (1) JP5728687B2 (en)
KR (1) KR20120024652A (en)
CN (1) CN102482270B (en)
AR (1) AR076709A1 (en)
AU (1) AU2010252339B2 (en)
BR (1) BRPI1012775A2 (en)
CA (1) CA2763386A1 (en)
CO (1) CO6470822A2 (en)
CR (1) CR20110627A (en)
CU (1) CU24011B1 (en)
DE (1) DE102009022894A1 (en)
EA (1) EA021944B1 (en)
HK (1) HK1171450A1 (en)
HN (1) HN2011003102A (en)
IL (1) IL215903A0 (en)
MA (1) MA33291B1 (en)
MX (1) MX2011012507A (en)
MY (1) MY166555A (en)
NZ (1) NZ596621A (en)
PE (1) PE20120402A1 (en)
SG (1) SG175759A1 (en)
TN (1) TN2011000596A1 (en)
TW (1) TWI464166B (en)
UA (1) UA107576C2 (en)
UY (1) UY32652A (en)
WO (1) WO2010136138A1 (en)
ZA (1) ZA201108609B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009014484A1 (en) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
DE102009022896A1 (en) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
DE102009022894A1 (en) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
GEP201706608B (en) 2011-10-07 2017-01-25 Takeda Pharmaceuticals Co 1 - arylcarbonyl - 4 - oxy – piperidine compounds useful for the treatment of neurodegenerative diseases
JP5900182B2 (en) * 2012-06-21 2016-04-06 セントラル硝子株式会社 Method for producing α, α-difluoroaromatic compound
JP6197348B2 (en) * 2013-04-25 2017-09-20 セントラル硝子株式会社 Method for improving storage stability of α, α-difluoroaromatic compounds

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767144A (en) 1994-08-19 1998-06-16 Abbott Laboratories Endothelin antagonists
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US6403612B2 (en) 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
CN1283252C (en) 2001-10-15 2006-11-08 詹森药业有限公司 Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage
DE10238113A1 (en) * 2001-12-11 2003-06-18 Bayer Ag New 2-substituted methylthio-dicyanopyridine derivatives, useful for treating or preventing e.g. cardiovascular disease and inflammation, are adenosine A1 receptor agonists
AU2005258248A1 (en) 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
EP1773773A4 (en) 2004-06-24 2009-07-29 Incyte Corp Amido compounds and their use as pharmaceuticals
BRPI0512535A (en) * 2004-06-24 2008-03-25 Incyte Corp unsubstituted piperidine compounds, their compositions and methods of modulation
BRPI0514230A (en) 2004-08-10 2008-06-03 Incyte Corp starch compounds and their use as pharmaceuticals
DE102004042607A1 (en) * 2004-09-03 2006-03-09 Bayer Healthcare Ag Substituted phenylaminothiazoles and their use
DE102004045796A1 (en) 2004-09-22 2006-03-23 Merck Patent Gmbh Medicaments containing carbonyl compounds and their use
EP1705960A1 (en) 2005-03-21 2006-09-27 IEE INTERNATIONAL ELECTRONICS & ENGINEERING S.A. Electroluminescent lamp
US20070066584A1 (en) 2005-09-21 2007-03-22 Wenqing Yao Amido compounds and their use as pharmaceuticals
EP1979318A1 (en) 2006-01-31 2008-10-15 Incyte Corporation Amido compounds and their use as pharmaceuticals
WO2007101270A1 (en) 2006-03-02 2007-09-07 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
US20070293529A1 (en) 2006-05-01 2007-12-20 Yun-Long Li Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
DK2227466T3 (en) * 2007-11-30 2011-08-08 Bayer Schering Pharma Ag Heteroaryl-substituted piperidines
DE102009014484A1 (en) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
DE102009022896A1 (en) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
DE102009022897A1 (en) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
DE102009022895A1 (en) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
DE102009022894A1 (en) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines
DE102009022892A1 (en) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituted piperidines

Also Published As

Publication number Publication date
CA2763386A1 (en) 2010-12-02
TW201107319A (en) 2011-03-01
TN2011000596A1 (en) 2013-05-24
MX2011012507A (en) 2011-12-14
TWI464166B (en) 2014-12-11
EA021944B1 (en) 2015-10-30
US20130252948A1 (en) 2013-09-26
NZ596621A (en) 2013-12-20
PE20120402A1 (en) 2012-04-18
CU24011B1 (en) 2014-06-27
CN102482270A (en) 2012-05-30
CN102482270B (en) 2015-02-25
ZA201108609B (en) 2013-02-27
CU20110214A7 (en) 2012-03-15
EP2435431A1 (en) 2012-04-04
US20100305111A1 (en) 2010-12-02
IL215903A0 (en) 2012-01-31
UA107576C2 (en) 2015-01-26
CR20110627A (en) 2012-03-22
DE102009022894A1 (en) 2010-12-02
EA201190313A1 (en) 2012-05-30
AU2010252339B2 (en) 2014-10-23
US8440657B2 (en) 2013-05-14
US20120135985A1 (en) 2012-05-31
US8202862B2 (en) 2012-06-19
AR076709A1 (en) 2011-06-29
SG175759A1 (en) 2011-12-29
BRPI1012775A2 (en) 2019-09-24
MA33291B1 (en) 2012-05-02
AU2010252339A1 (en) 2011-12-08
MY166555A (en) 2018-07-16
CO6470822A2 (en) 2012-06-29
UY32652A (en) 2010-12-31
KR20120024652A (en) 2012-03-14
WO2010136138A1 (en) 2010-12-02
JP5728687B2 (en) 2015-06-03
HK1171450A1 (en) 2013-03-28
JP2012528089A (en) 2012-11-12

Similar Documents

Publication Publication Date Title
UY31484A1 (en) HETEROARIL-SUBSTITUTED PIPERIDINS
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
SV2011004019A (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONS AND ITS USE
GT200900230A (en) 4-ARIL-1,4-DIHIDRO-1,6-NAFTIRIDINAMIDES REPLACED AND USE
CO7240369A2 (en) Novel 5-aminotetrahydroquinolin-2-carboxylic acid and its use
ECSP11011483A (en) SUBSTITUTED PIPERIDINS
UY30663A1 (en) SUBSTITUTED DIHYDROPIRAZOLONAS AND ITS USE
WO2013151666A3 (en) Modified polynucleotides for the production of biologics and proteins associated with human disease
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
HN2010002518A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A STRONTIUM SALT, VITAMIN D AND A CYCLODEXTRINE
EA201200551A1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSED FORM, METHODS OF THEIR PRODUCTION AND APPLICATION FOR TREATMENT
SV2010003581A (en) 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE
CO6300844A2 (en) DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF-PROPIL-4-HYDROXYLASE
DK3045456T3 (en) BICYCLICALLY SUBSTITUTED URACILES AND APPLICATION
HN2011003102A (en) SUBSTITUTED PIPERIDINS
ECSP099807A (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND ITS USE IN THE FIELD OF THE BLOOD COAGULATION
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
BR112013020359B8 (en) Gelable collagen and means for its provision
DOP2015000290A (en) BENZOXAZOLES REPLACED
HN2010001125A (en) 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE
CU20100183A7 (en) DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF-PROPIL-4-HYDROXYLASE